FCC
IBB icon

Florin Court Capital’s iShares Biotechnology ETF IBB Stock Holding History

Florin Court Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Buy
14,900
+8,600
+137% +$1.48M 4.63% 9
2026
Q1 		$1.06M Sell
6,300
-23,800
-79% -$4.07M 4.01% 9
2025
Q4 		$5.08M Sell
30,100
-46,900
-61% -$7.62M 7.07% 3
2025
Q3 		$11.1M Buy
+77,000
New +$10.5M 8.71% 2
2025
Q2 		– Sell
-6,100
Closed -$780K – 33
2025
Q1 		$780K Buy
+6,100
New +$827K 0.81% 23
2024
Q4 		– Sell
-24,800
Closed -$3.61M – 29
2024
Q3 		$3.61M Buy
24,800
+21,100
+570% +$3.05M 2.9% 13
2024
Q2 		$508K Sell
3,700
-11,700
-76% -$1.56M 0.7% 25
2024
Q1 		$2.11M Buy
+15,400
New +$2.1M 1.82% 21
2022
Q1 		– Sell
-2,500
Closed -$382K – 28
2021
Q4 		$382K Buy
2,500
+500
+25% +$77.4K 0.24% 29
2021
Q3 		$323K Sell
2,000
-5,800
-74% -$976K 0.31% 34
2021
Q2 		$1.28M Buy
7,800
+3,500
+81% +$539K 0.73% 24
2021
Q1 		$647K Sell
4,300
-4,200
-49% -$667K 0.68% 22
2020
Q4 		$1.29M Buy
8,500
+3,100
+57% +$443K 0.65% 24
2020
Q3 		$731K Buy
5,400
+2,700
+100% +$366K 0.69% 19
2020
Q2 		$369K Buy
+2,700
New +$344K 0.53% 15
2020
Q1 		– Sell
-7,100
Closed -$856K – 13
2019
Q4 		$856K Buy
+7,100
New +$792K 0.37% 28
2018
Q4 		– Sell
-11,200
Closed -$1.37M – 18
2018
Q3 		$1.37M Buy
11,200
+9,000
+409% +$1.06M 0.41% 18
2018
Q2 		$242K Buy
+2,200
New +$235K 0.24% 22
2018
Q1 		– Sell
-3,400
Closed -$363K – 23
2017
Q4 		$363K Buy
3,400
+1,600
+89% +$171K 0.13% 26
2017
Q3 		$200K Buy
+1,800
New +$192K 0.12% 27

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Florin Court Capital's IBB Position: Q2 2026 in Review

Florin Court Capital increased its iShares Biotechnology ETF (IBB) stake by 137% in Q2 2026, buying an estimated $1.48M and bringing the position to 14,900 shares worth $2.83M. The position accounts for 4.63% of the portfolio, ranked #9.

Florin Court Capital first reported a position in IBB in Q3 2017 and has held it in 20 quarters since. The position peaked at $11.1M in Q3 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Florin Court Capital held 14,900 shares of iShares Biotechnology ETF worth $2.83M as of Q2 2026.
  • Florin Court Capital bought 8,600 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.48M.
  • iShares Biotechnology ETF made up 4.63% of Florin Court Capital's portfolio in Q2 2026, its #9 holding.
  • Florin Court Capital first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 20 quarters since.
  • Florin Court Capital's iShares Biotechnology ETF position peaked at $11.1M in Q3 2025.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Florin Court Capital's 13F filing for Q2 2026, filed 4 Aug 2026.